Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT. (2022)
Attributed to:
Using human IPSC derived nociceptors as a cellular model to investigate and therapeutically target Nav1.7
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3310/rxuo6757
PubMed Identifier: 36259684
Publication URI: http://europepmc.org/abstract/MED/36259684
Type: Journal Article/Review
Volume: 26
Parent Publication: Health technology assessment (Winchester, England)
Issue: 39
ISSN: 1366-5278